John Carroll deserves a Twitter response. His work is viewed and extensively referenced by journalists and investors. He's being a smart alec and is showing his jaded belief in the potential of the very system that feeds him.

But, in fact, he doesn't need to write about new technologies. Measurable successes in the pharmaceutical industry provide him with enough news to fill his website.

jdstox